2/19/26 18:36 | 2/17/26 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | M.d | 112 | 2.48 | 0 | 45 | | 25 | D | | | | | | | | | | | | | | |
2/19/26 18:36 | 2/17/26 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | S.d | -1,178 | 26.17 | 0 | -45 | -64 | 25 | D | | | | | | | | | | | | | | |
10/22/24 16:17 | 10/18/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | M.d | 2 | 2.48 | 0 | 1 | | 0 | D | | | | | | | | | | | | | | |
10/22/24 16:17 | 10/18/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | S.d | -24 | 30.00 | 0 | -1 | -100 | 0 | D | | | | | | | | | | | | | | |
4/15/24 19:02 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | M.d | 50 | 2.48 | 0 | 20 | | 0 | D | | | | | | | | | | | | | | |
4/15/24 19:02 | 4/11/24 | ELVN | Enliven Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CO | O | Chief Me | S.d | -501 | 25.07 | 0 | -20 | -100 | 0 | D | | | | | | | | | | | | | | |
12/15/20 12:00 | 12/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 22 | 35 | 86 | D | | | | | | | | | | | | | | |
11/13/20 12:25 | 11/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Collins Helen Louise | CA | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 22 | 41 | 75 | D | | | | | | | | | | | | | | |